Skip to content

Functional Electrical Stimulation-Assisted Walking: Reduction of Secondary Complications Due to Spinal Cord Injury

Functional Electrical Stimulation-Assisted Walking: Reduction of Secondary Complications Due to Spinal Cord Injury

Status
UNKNOWN
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00201968
Enrollment
32
Registered
2005-09-20
Start date
2005-04-30
Completion date
2013-04-30
Last updated
2013-02-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Spinal Cord Injury

Brief summary

The purpose of this study is to evaluate whether an aerobic and resistance training program or a functional electrical stimulation-assisted Walking program is more effective for reducing health complications related to spinal cord injury, for example, the occurrence of bladder infections, pressure sores and/or frequency of spasms. It is hypothesized that the functional electrical stimulation-assisted walking will have a greater impact on secondary complications than the aerobic and resistance training program.

Detailed description

A barrier to maintaining health status and active social participation in the community for individuals with spinal cord injury (SCI) is the broad number of secondary medical complications typically associated with their injury, such as bone loss, spasticity, urinary tract infections and pressure sores. Functional electrical stimulation (FES) is an intervention that applies short current pulses to muscles and causes them to contract. FES can be applied to individuals with SCI to help them restore functions such as walking and grasping by contracting groups of paralyzed muscles in an orchestrated manner. Pilot work conducted by our research group suggests that applying FES to augment functional improvement often reduces incidents of secondary complications such as spasticity, pressure sores, and swelling of the legs. Specifically, functional and meaningful walking tasks performed on a regular basis with the help of FES therapy have the potential to improve overall physical and psychological well being of persons with incomplete SCI. This study seeks to demonstrate that thrice-weekly FES training for 4 months can restore/improve walking function in chronic, incomplete SCI individuals and that this therapy will considerably reduce the occurrences of secondary complications due to SCI. This will subsequently promote opportunities for active social participation and enhance the quality of life for SCI consumers. Comparison: 32 individuals with chronic, incomplete SCI will be randomized to either thrice-weekly FES therapy OR thrice-weekly aerobic and resistance training. The study will determine which therapy is superior for improving walking function and reducing secondary complications associated with SCI after 4 months of training, and after 2-month and 8-month follow-up periods.

Interventions

Functional Electrical Stimulation applied to the lower limbs of SCI individuals in order to stimulate walking while on Body Weight Support Treadmill

OTHERConventional Exercise

An aerobic and resistance training program.

Sponsors

Ontario Neurotrauma Foundation
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* incomplete spinal cord lesion of sudden onset between C6 and T12 that is motor incomplete (grade C or D on the ASIA neurological impairment scale). The injury must have occurred at least two years prior to recruitment

Exclusion criteria

* contraindications for FES, such as cardiac pacemakers, skin lesions or rush at potential electrode sites, or denervation of targeted muscles. * pressure ulcers anywhere on the lower extremities * hypertension that is uncontrolled * symptoms of orthostatic hypotension when standing for 15 minutes * susceptibility to autonomic dysreflexia, requiring medication. * if there is a history of cardiovascular disease, participants must obtain medical clearance from their physician before inclusion

Design outcomes

Primary

MeasureTime frame
Whole body muscle mass via dual-energy x-ray absorptiometryBaseline, 4 month and 12 months
Bone density at different hip, spine, proximal and distal femur and proximal Tibia using dual-energy xray absorptiometryBaseline, 4 month and 12 months
Bone density, bone geometry and muscle area via computed tomography,Baseline, 4 month and 12 months
Spasticity via Ashworth Scale and Pendulum Test, andBaseline, 4 months, 6 months and 12 months
Factor analysis of electromyography and kinematics of gait.Baseline, 4months and 6 months

Secondary

MeasureTime frame
Reintegration to normal living index,Baseline, 4, 6 and 12 months
Satisfaction with life scale,Baseline, 4 , 6 and 12 months
Incidence of urinary tract infections,Over 12 months
Craig Handicap assessment and reporting technique, andBaseline, 4, 6 and 12 months
client perception of treatment (qualitative).At 12 months
Instrumental Activities of Daily Living SubScale,Baseline, 4, 6 and 12 months
Spinal cord independence measure,Baseline and 12 months
Urinary N-telopeptide and serum osteocalcin,Baseline, 4 month, 6 month and 12 months
Timed up and go and two-minute walk test (functional mobility),Baseline, 4 months, 6 months and 12 months
Incidence of pressure sores,Over 12 months

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 24, 2026